Connection

Robert Stuart to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Robert Stuart has written about Protein Kinase Inhibitors.
Robert Stuart
Connection Strength
0.435
Protein Kinase Inhibitors
  1. Developmental therapeutics in acute myelogenous leukemia: are there any new effective cytotoxic chemotherapeutic agents out there? Curr Hematol Malig Rep. 2013 Jun; 8(2):156-62.
    View in: PubMed
    Score: 0.347
  2. Lestaurtinib, a multitargeted tyrosine kinase inhibitor: from bench to bedside. Expert Opin Investig Drugs. 2010 Mar; 19(3):427-36.
    View in: PubMed
    Score: 0.069
  3. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood. 2011 Mar 24; 117(12):3294-301.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.